期刊文献+

灾难性抗磷脂综合征 被引量:5

原文传递
导出
摘要 抗磷脂综合征(antiphospholipid syndrome,APS),是由抗磷脂抗体(antiphospholipid antibody,APL)引起的临床综合征,主要表现为动脉/静脉血栓和/或病理妊娠。1992年Asherson首次报道10例APL阳性的患者,均在短期(几小时至几天)内出现多血管栓塞和急性多器官功能衰竭。其发病急、病情重、死亡率高、APL均阳性,故命名为灾难性抗磷脂综合征(catastrophic antiphospholipid syndrome,CAPS)。不到1%的APS患者会出现CAPS,部分CAPS患者既往未诊断APS或其他自身免疫疾病,称“de-novo”CAPS。早期诊断和及时治疗有利于改善CAPS预后,本文就CAPS的诊治进展进行综述。
作者 孙玲 张烜
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第45期3238-3240,共3页 National Medical Journal of China
  • 相关文献

参考文献26

  • 1冷晓梅,刘晓敏,艾脉兴,曾小峰,唐福林.抗磷脂综合征61例临床分析[J].中华医学杂志,2004,84(16):1367-1370. 被引量:18
  • 2Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1 000 patients. Arthritis Rheum, 2002, 46 : 1019-1027.
  • 3Levine JS, Branch DW, Rauch J. The antiphospholipid Syndrome. N Engl J Med, 2002, 346: 752-763.
  • 4Asherson RA. The catastrophic antiphospholipid ( Asherson' s ) syndrome. Autoimmun Rev, 2006, 6: 64-67.
  • 5Cervera R, Asherson RA. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis, 2004, 63: 1312-1317.
  • 6Blank M, Asherson RA, Cervera R, et al. Antiphospholipid syndrome infectious origin. J Clin Immunol, 2004 24: 12-23.
  • 7Raschi E, Testoni C, Borghi MO, et al. Endothelium activation in the antiphospholipid syndrome. Biomed Pharmacother, 2003,7: 282-286.
  • 8Pierangeli SS, Girardi G, Vega OM, et al. Requirement of activation of complement C3 and C5 for antiphospholipid antibody mediated thrombosis. Arthritis Rheum, 2005, 52: 2120-2124.
  • 9Fleming SD, Egan RE, Chai C, et al. Anti-phospholipid antibodies restore mesenteric ischemia reperfusion-induced injury in complement receptor 2 / complement receptor 1 -deficient mice. J Immunol, 2005, 173: 7055-7061.
  • 10Kitchens C. Thrombotic storm : when thrombosis begets thrombosis. Am J Med, 1998, 104: 381-385.

二级参考文献10

  • 1王元,顾懿,周烈,陈顺乐.SLE患者抗磷脂抗体纵行观察的初步分析[J].上海医学,1994,17(9):504-507. 被引量:5
  • 2Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome,clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum, 2002, 46:1019-1027.
  • 3Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med, 1994, 96: 3-9.
  • 4Avcin T, Cimas R, Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations.Lupus, 2002, 11: 4-10.
  • 5Durrani OM, Gordon C, Murray PI. Primary anti-phospholipid antibody syndrome (APS): current concepts. Surv Ophthalmol,2002,47: 215-238.
  • 6Rai R, Cohen H, Dave M, et al. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies. BMJ, 1997,314: 253-257.
  • 7Juanola X, Mateo L, Domenech P, et al. Prevalence of antiphospholipid antibodies in patients with ankylosing spondylitis. J Rheumatol, 1995, 22:1891-1893.
  • 8Deleze M, Alarcon-Segnvia D, Oria CM, et al. Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol, 1989, 16: 926-930.
  • 9Cuadrado MJ, Mujic F, Munoz E, et al. Thrombocytopenia in the antiphospholipid syndrome. Ann Rheum Dis, 1997, 56:194-196.
  • 10Triolo G, Ferrante A, Ciccia F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum, 2003

共引文献17

同被引文献33

  • 1黄璨,赵久良,王迁,李梦涛,田新平,曾小峰.灾难性抗磷脂综合征患者的临床特征及预后[J].中华临床免疫和变态反应杂志,2019,13(4):288-293. 被引量:8
  • 2王金泉,唐政.抗磷脂综合征的诊断与治疗[J].中国实用内科杂志,2007,27(11):879-881. 被引量:5
  • 3Asherson R A. The catastrophic antiphospholipid syndrome [J]. J Rheumatol, 1992,19(4) :508-512.
  • 4Hughes G R. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant [ J ]. BMJ, 1983,287 ( 6399 ) : 1088- 1089.
  • 5Cervera R, Espinosa G, Bucciarelli S, et al. Lessons from the catastrophic antiphospholipid syndrome (CAPS) regis- try [ J ].Autoimmun Rev, 2006,6 ( 2 ) : 81-84.
  • 6Cervera R. CAPS Registry[ J ]. Lupus, 2012,21 (7) :755- 757.
  • 7Baker W F, Bick R L. The clinical spectrum of antiphos- pholipid syndrome [ J ]. Hematol Oncol Clin N, ;:008,22 ( 1 ) :33-52.
  • 8Espinosa G, Rodrfguez-Pint6 I, Gomez-Puerta J A, et al. Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Anti- bodies). Relapsing Catastrophic Antiphospholipid Syn- drome Potential Role of Microangiopathic Hemolytic Ane- mia in Disease Relapses [ J ]. Semin Arthritis Rheum, [2012-7-9]. [ Epub ahead of print].
  • 9Costedoat-Chalumeau N, Arnaud L, Saadoun D, et al. Catastrophic antiphospholipid syndrome [ J]. Rev Med In-terne, 2012,33(4) :194-199.
  • 10A1-Beladi F I. Catastrophic antiphospholipid syndrome presenting as fever of unknown origin [ J ]. S, audi J Kidney Dis Transpl, 2012,23 ( 1 ) : 110-113.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部